About Mojia Biotech
Mojia Biotech is a Chemicals & Materials company based in Shanghai (China) founded in 2017. Animal feed additives are developed as supplements by Mojia Biotech. Mojia Biotech has raised $80 million across 1 funding round from investors including Temasek, Sento.io and LYZZ Capital. Its chief executive, as recorded, is Indra Jones Santana. Mojia Biotech offers products and services including Biomanufacturing Solutions and Green Feedstocks. Its focus areas include Chemicals and Materials, Diversified Chemicals and Diversified. Its legal entity is MOJIABIO.
Company details
Mojia Biotech was established in 2017 in Shanghai, China, within the biotechnology sector. Additives for animal feed are produced as nutritional supplements. The Viridimin range, featuring vitamin B5 formulations, is supplied for integration into animal nutrition. Furthermore, Aliphane, a bio-polymer material, is manufactured for applications in coatings and adhesives. Core operations center on these product lines to support agricultural and industrial needs.
- Headquarters Shanghai, China
- SectorsChemicals & Materials
- Email••••••••
- Phone•••• ••••
- Website mojiabio.com
- Legal Name Mojiabio
- Total Equity Funding$80M (USD)
in 1 rounds
- Latest Funding Round$80M (USD), Series B
Jun 2022
- InvestorsTemasek
& 4 more
Products & Services of Mojia Biotech
Mojia Biotech offers a comprehensive portfolio of products and services, including Biomanufacturing Solutions and Green Feedstocks.
Develops sustainable chemical and agricultural additives via AI and engineering
Produces eco-friendly inputs for industrial applications using biology
Funding Insights of Mojia Biotech
Mojia Biotech has successfully raised a total of $80M through 1 strategic funding round. The most recent funding activity was a Series B round of $80 million completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $80M
- Total Rounds 1
- Last Round Series B — $80M
- First Round $80M
(Jun 2022)
- Investors Count 5
All 1 funding rounds of Mojia Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2022 | $80M | Series B | – | Temasek |
5 investors in total: 5 institutional.
Investors in Mojia Biotech
Mojia Biotech has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Temasek, Sento.io and LYZZ Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
An investment platform is provided for diverse sectors and geographies. | 1974 | temasek.com.sg | Singapore, Singapore | |
A global healthcare-focused VC/PE firm is operated. | lyzzcap.com | Shanghai, China | ||
A venture capital firm focused on agriculture and food technology. | bitsxbites.com | Shanghai, China | ||
| asiagreenfund.com | ||||
Cloud-based EDI software is provided for integrated document exchange. | 2020 | sento.io | Munich, Germany |
Investor details for Mojia Biotech
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Mojia Biotech
1 people are tracked at Mojia Biotech (1 in leadership).
| Name | Role | Group |
|---|---|---|
Indra Jones Santana | CEO | Leadership |
Complete people profiles for Mojia Biotech
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Mojia Biotech
2 dated milestones of Mojia Biotech across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Mojia Biotech is founded.
- Funding First funding round of $80.0M.
Web traffic of Mojia Biotech
The website of Mojia Biotech (mojiabio.com) receives about 1.3K visits a month.
- Monthly visits1.3K
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mojia Biotech
Complete news archive for Mojia Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mojia Biotech
Mojia Biotech was founded in 2017 and raised its 1st funding round 5 years after it was founded.
Mojia Biotech is headquartered in Shanghai, China.
Indra Jones Santana is the CEO of Mojia Biotech, as recorded in our data.
Mojia Biotech is a funded company, having raised a total of $80M across 1 funding round to date. The company's 1st funding round was a Series B of $80M, raised on Jun 2022.
Mojia Biotech was established in 2017 in Shanghai, China, within the biotechnology sector. Additives for animal feed are produced as nutritional supplements. The Viridimin range, featuring vitamin B5 formulations, is supplied for integration into animal nutrition. Furthermore, Aliphane, a bio-polymer material, is manufactured for applications in coatings and adhesives. Core operations center on these product lines to support agricultural and industrial needs.
Mojia Biotech offers Biomanufacturing Solutions and Green Feedstocks.
Mojia Biotech has 5 investors. Key investors include Temasek, Sento.io, LYZZ Capital, Bits x Bites, and Asia Green Fund.
Mojia Biotech operates through Mojiabio.